STD News

2013 STD Surveillance Statistics
Graphs, tables and text that describe trends in sexually transmitted diseases (STDs) in Minnesota. Includes data on: Chlamydia, Gonorrhea, Syphilis and Chancroid.
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | Archive

2013 HIV/AIDS Surveillance Reports
Number and demographic characteristics of newly diagnosed HIV/AIDS cases in Minnesota.
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | Archive

Minnesota Treatment Cascade for People Living with HIV/AIDS
As part of the National HIV/AIDS Strategy for the United States, MDH has calculated an HIV treatment cascade using HIV surveillance data. These calculations help us better understand the HIV epidemic and the disparities that exist in the delivery of care among HIV positive people in Minnesota. (September 2013)
 
Shigellosis Factsheet for Men who have Sex with Men (MSM) (PDF: 24KB/2 pages)
The Minnesota Department of Health (MDH) has observed an increase in reported shigellosis infections in Minneapolis among men who have sex with men (MSM). Four (4) cases were diagnosed in November among white, non-Hispanic, MSM.
 
Updated Syphilis Clinical Training Available 
Syphilis Self Study Module - Web-based training course designed to guide clinicians in the diagnosis, treatment, and prevention of syphilis. Continuing education credits available. 
 
Ready to Use Syphilis Curriculum for Clinical Educators
Comprehensive curricular materials that can be downloaded by clinical educators for classroom use. Each module contains a slide presentation, an instructor's guide, a case study, and test questions.
 
CDC STD Treatment Guidelines now available formatted for iPhones/iPads
 
Update to CDC’s 2010 STD Treatment Guidelines: Oral Cephalosporins No Longer Recommended Treatment for GC Infections
On August 9, 2012 the U.S. Centers for Disease Control and Prevention published “Update to CDC’s Sexually Transmitted Diseases Treatment 2010 Guidelines: Oral Cephalosporins No Longer A Recommended Treatment for Gonococcal Infections,” in Morbidity and Mortality Weekly Report. The most significant change is that CDC now recommends a dual therapy of injectable ceftriaxone in combination with a second antibiotic. CDC no longer recommends an exclusively oral treatment regimen for gonorrhea.
 
Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945–1965 in the CDC's Morbidity and Mortality Weekly Report. The new recommendations call for all Americans born from 1945 through 1965 or “baby boomers” to get a one-time blood test for the hepatitis C virus (HCV).
 
Minnesota Chlamydia Partnership: The Chlamydia Strategy
A user-friendly version of the Minnesota Chlamydia Strategy in booklet form is available.
 
Minnesota Adolescent Sexual and Reproductive Health Databook 2012 (PDF:4.47MB/62 pagess), produced by the Maternal and Child Health Program of the Minnesota Department of Health
 
HIV/AIDS among Men Who Have Sex with Men in Minnesota
Men who have sex with men (MSM) and men who have sex with men and use injection drugs (MSM/IDU) remain at increased risk for HIV infection in MN.
 
Food and Drug Administration - Fraudulent Products: Sexually Transmitted Diseases (STDs)
Important information on bogus STD treatments
 
Sexual Health Site
Sexual health is a state of physical, emotional, mental and social well being in relation to sexuality; it is not merely the absence of disease, dysfunction or infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, discrimination and violence.
 
Survey Results: The Use of Expedited Partner Therapy (EPT) in Minnesota
Results of an evaluation survey conducted by MDH in 2010 to determine the extent to which EPT is currently being used in Minnesota, as well as to identify challenges and successes that have been experienced and technical assistance needs related to implementing EPT.
 
Dear Colleague Letter
Azithromycin resistance in Hawaii (May 24, 2011)
 
Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota
The Minnesota Chlamydia Partnership (MCP) and the STD, HIV and TB Section of the Minnesota Department of Health (MDH) present the Strategy for Reducing and Preventing Chlamydia in Minnesota, the first-ever action plan to address the epidemic of the sexually transmitted disease chlamydia.
 
Dear Colleague Letter (PDF: 32KB/1 page)
The Minnesota Department of Health (MDH) requests that you take a sexual history screen for syphilis, provide prevention counseling, and solicit partners when appropriate for all your male patients in light of an alarming 87 percent increase in early syphilis cases. Dated 02/2010.
 

The MMWR of the 2010 STD Treatment Guidelines published electronically on December 17, 2010 contains incorrect dosage information. MMWR will issue an erratum by January 14, 2011. Three significant corrections pertain to the recommended regimens for gonococcal infections, which include gonococcal dual therapy, and the alternative regimens for bacterial vaginosis.

Corrected pages to the print version (pages 50, 51, and 57) of the MMWR are available on the CDC Division of STD Prevention web site at http://www.cdc.gov/std/treatment/.
 
CDC’s 2010 STD Treatment Guidelines: http://www.cdc.gov/std/treatment/
2010 Treatment Guidelines Webinar: http://www.stdhivtraining.org/presentation_description.html?id=24
 
Epidemiological Profile of HIV/AIDS in Minnesota
The epidemiological (epi) profile presents data on the HIV epidemic in the state of Minnesota. The profile is intended to give the Community Cooperative Council on HIV/AIDS Prevention (CCCHAP) and the Minnesota HIV Services Planning Council (Planning Council).
 
STD/HIV Laboratory Survey
In 2008, MDH conducted a survey of 120 laboratories to assess STD testing and reporting practices.  The results for chlamydia, gonorrhea, syphilis and HIV testing and reporting practices from survey respondents are now available.
 
CDC National HIV Incidence Estimates: Frequently Asked Questions
 
MDH Dear Colleague Letter on Gonorrhea Treatment, June 2008 (PDF: 39KB/1 page)
CDC’s Gonorrhea Treatment Guidelines Attention: Non-MDH web link.
 
FDA Warning: Unapproved Over The Counter Drugs Marketed for Prevention and Treatment of STDs
FDA issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs). [Posted 03/06/2008]
 
Hepatitis B ECHO-TV Program
Videos available in seven languages with information on hepatitis B awareness and prevention
 
HIV/STD/Hepatitis Risk Assessment
MDH's integrated risk assessment tool for health and social service providers.
 


Content Notice: This site contains HIV or STD prevention messages that may not be appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site.

 

Updated Thursday, August 28, 2014 at 01:17PM